ArticleCell reports. Medicine2025

Screening a living biobank identifies cabazitaxel as a strategy to combat acquired taxol resistance in high-grade serous ovarian cancer.

Anthony Tighe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.